Metraipolis › archive › dc_4e45b6898a7a

Efficacy and safety of upadacitinib in the treatment of rheumatoid arthritis: a systematic review and meta-analysis — Europe PMC PMID:42245676

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42245676
DOI
10.3389/fimmu.2026.1806265
License (as archived)
solo-consultazione
Archived
2026-11-01T12:59:37.160Z
SHA-256 of the archived text
e175465f39ea52660673f805f1fc8bdec31973d2eb057cfec6238eec95678030
Stable URL of this page
https://metraipolis.com/documento/dc_4e45b6898a7a

How to cite

Efficacy and safety of upadacitinib in the treatment of rheumatoid arthritis: a systematic review and meta-analysis — Europe PMC PMID:42245676 — Europe PMC (en), https://europepmc.org/article/MED/42245676 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4e45b6898a7a (Metraipolis archive dc_4e45b6898a7a, sha256 e175465f39ea52660673f805f1fc8bdec31973d2eb057cfec6238eec95678030)
BibTeX
@misc{dc4e45b6898a7a,
  title = {Efficacy and safety of upadacitinib in the treatment of rheumatoid arthritis: a systematic review and meta-analysis — Europe PMC PMID:42245676},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42245676},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4e45b6898a7a; sha256 e175465f39ea52660673f805f1fc8bdec31973d2eb057cfec6238eec95678030},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42245676. Agents can read the archived copy with the MCP tool read_document.